{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,11]],"date-time":"2026-02-11T13:42:22Z","timestamp":1770817342658,"version":"3.50.1"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T00:00:00Z","timestamp":1740096000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T00:00:00Z","timestamp":1740096000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cancer"],"DOI":"10.1186\/s12885-025-13747-3","type":"journal-article","created":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T03:25:45Z","timestamp":1740108345000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Primary tumour resection in non-small cell lung cancer patients with pleural dissemination unexpectedly detected during operation: a two-centre retrospective cohort study"],"prefix":"10.1186","volume":"25","author":[{"given":"Tao","family":"Bao","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuanlin","family":"Deng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Liang","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Weijie","family":"Sun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mingjian","family":"Ge","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaolong","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xu","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Liang","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yingjian","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiandong","family":"He","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiangshu","family":"Pu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yan","family":"He","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jun","family":"Yu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wei","family":"Guo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,2,21]]},"reference":[{"issue":"1","key":"13747_CR1","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.jtho.2015.09.009","volume":"11","author":"P Goldstraw","year":"2016","unstructured":"Goldstraw P, Chansky K, Crowley J, et al. The IASLC Lung Cancer Staging Project: proposals for revision of the TNM Stage groupings in the Forthcoming (Eighth) Edition of the TNM classification for Lung Cancer. J Thorac Oncol. 2016;11(1):39\u201351.","journal-title":"J Thorac Oncol"},{"issue":"6","key":"13747_CR2","first-page":"1444","volume":"40","author":"P Mordant","year":"2011","unstructured":"Mordant P, Arame A, Foucault C, Dujon A, Le Pimpec Barthes F, Riquet M. Surgery for metastatic pleural extension of non-small-cell lung cancer. Eur J Cardiothorac Surg. 2011;40(6):1444\u20139.","journal-title":"Eur J Cardiothorac Surg"},{"issue":"7","key":"13747_CR3","doi-asserted-by":"publisher","first-page":"1076","DOI":"10.1097\/JTO.0000000000000554","volume":"10","author":"T Iida","year":"2015","unstructured":"Iida T, Shiba M, Yoshino I, et al. Surgical intervention for non-small-cell Lung Cancer patients with Pleural Carcinomatosis: results from the Japanese Lung Cancer Registry in 2004. J Thorac Oncol. 2015;10(7):1076\u201382.","journal-title":"J Thorac Oncol"},{"issue":"6","key":"13747_CR4","doi-asserted-by":"publisher","first-page":"1121","DOI":"10.1093\/ejcts\/ezy439","volume":"55","author":"H Li","year":"2019","unstructured":"Li H, Sun Z, Yang F, Sui X, Liu T, Wang J. Primary tumour resection in non-small-cell lung cancer patients with ipsilateral pleural dissemination (M1a): a population-based study. Eur J Cardiothorac Surg. 2019;55(6):1121\u20139.","journal-title":"Eur J Cardiothorac Surg"},{"issue":"3","key":"13747_CR5","doi-asserted-by":"publisher","first-page":"1238","DOI":"10.1016\/j.jtcvs.2017.09.162","volume":"155","author":"C Li","year":"2018","unstructured":"Li C, Kuo SW, Hsu HH, Lin MW, Chen JS. Lung adenocarcinoma with intraoperatively diagnosed pleural seeding: is main tumour resection beneficial for prognosis? J Thorac Cardiovasc Surg. 2018;155(3):1238\u2013e12491.","journal-title":"J Thorac Cardiovasc Surg"},{"issue":"10","key":"13747_CR6","doi-asserted-by":"publisher","first-page":"3851","DOI":"10.21037\/jtd.2017.09.112","volume":"9","author":"S Li","year":"2017","unstructured":"Li S, Zhang S, Huang M, Ma Y, Yang Y. Management of occult malignant pleural disease firstly detected at thoracotomy for non-small cell lung cancer patients. J Thorac Dis. 2017;9(10):3851\u20138.","journal-title":"J Thorac Dis"},{"issue":"11","key":"13747_CR7","doi-asserted-by":"publisher","first-page":"6697","DOI":"10.1245\/s10434-023-13791-y","volume":"30","author":"T Fujiwara","year":"2023","unstructured":"Fujiwara T, Shien K, Matsuura M, et al. EGFR Mutation is a prognostic factor in Lung Cancer patients with Pleural Dissemination detected during or after surgery. Ann Surg Oncol. 2023;30(11):6697\u2013702.","journal-title":"Ann Surg Oncol"},{"issue":"21","key":"13747_CR8","doi-asserted-by":"publisher","first-page":"2866","DOI":"10.1200\/JCO.2010.33.4235","volume":"29","author":"M Fukuoka","year":"2011","unstructured":"Fukuoka M, Wu YL, Thongprasert S, et al. Biomarker analyses and final overall survival results from a phase III, randomized, open-label, first-line study of gefitinib versus carboplatin\/paclitaxel in clinically selected patients with advanced non-small-cell lung cancer in Asia (IPASS). J Clin Oncol. 2011;29(21):2866\u201374.","journal-title":"J Clin Oncol"},{"issue":"2","key":"13747_CR9","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1056\/NEJMoa1504627","volume":"373","author":"J Brahmer","year":"2015","unstructured":"Brahmer J, Reckamp KL, Baas P, et al. Nivolumab versus Docetaxel in Advanced squamous-cell non-small-cell Lung Cancer. N Engl J Med. 2015;373(2):123\u201335.","journal-title":"N Engl J Med"},{"issue":"10183","key":"13747_CR10","doi-asserted-by":"publisher","first-page":"1819","DOI":"10.1016\/S0140-6736(18)32409-7","volume":"393","author":"TSK Mok","year":"2019","unstructured":"Mok TSK, Wu YL, Kudaba I, et al. Pembrolizumab versus chemotherapy for previously untreated, PD-L1-expressing, locally advanced or metastatic non-small-cell lung cancer (KEYNOTE-042): a randomised, open-label, controlled, phase 3 trial. Lancet. 2019;393(10183):1819\u201330.","journal-title":"Lancet"},{"issue":"8","key":"13747_CR11","doi-asserted-by":"publisher","first-page":"764","DOI":"10.1001\/jama.2019.11058","volume":"322","author":"KC Arbour","year":"2019","unstructured":"Arbour KC, Riely GJ. Systemic therapy for locally Advanced and Metastatic Non-small Cell Lung Cancer: a review. JAMA. 2019;322(8):764\u201374.","journal-title":"JAMA"},{"key":"13747_CR12","doi-asserted-by":"publisher","first-page":"n2363","DOI":"10.1136\/bmj.n2363","volume":"375","author":"M Miller","year":"2021","unstructured":"Miller M, Hanna N. Advances in systemic therapy for non-small cell lung cancer. BMJ. 2021;375:n2363.","journal-title":"BMJ"},{"issue":"1","key":"13747_CR13","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1002\/cac2.12505","volume":"44","author":"D Miao","year":"2024","unstructured":"Miao D, Zhao J, Han Y, et al. Management of locally advanced non-small cell lung cancer: state of the art and future directions. Cancer Commun (Lond). 2024;44(1):23\u201346.","journal-title":"Cancer Commun (Lond)"},{"issue":"2","key":"13747_CR14","first-page":"183","volume":"3","author":"TD Yan","year":"2014","unstructured":"Yan TD. Surgical atlas of thoracoscopic lobectomy and segmentectomy. Ann Cardiothorac Surg. 2014;3(2):183\u201391.","journal-title":"Ann Cardiothorac Surg"},{"issue":"6","key":"13747_CR15","doi-asserted-by":"publisher","first-page":"949","DOI":"10.3892\/mco.2013.164","volume":"1","author":"M Kimura","year":"2013","unstructured":"Kimura M, Murakami H, Naito T, et al. Outcome of platinum-based chemotherapy for non-small-cell lung cancer patients with pleural dissemination detected during surgery. Mol Clin Oncol. 2013;1(6):949\u201352.","journal-title":"Mol Clin Oncol"},{"issue":"2","key":"13747_CR16","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1016\/S0003-4975(01)03426-9","volume":"73","author":"N Sawabata","year":"2002","unstructured":"Sawabata N, Matsumura A, Motohiro A, et al. Malignant minor pleural effusion detected on thoracotomy for patients with non-small cell lung cancer: is tumour resection beneficial for prognosis? Ann Thorac Surg. 2002;73(2):412\u20135.","journal-title":"Ann Thorac Surg"},{"issue":"1","key":"13747_CR17","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1186\/s12885-021-08180-1","volume":"21","author":"J Hu","year":"2021","unstructured":"Hu J, Chen Y, Zhu X, et al. Surgical choice of non-small cell lung cancer with unexpected pleural dissemination intraoperatively. BMC Cancer. 2021;21(1):445.","journal-title":"BMC Cancer"},{"issue":"9","key":"13747_CR18","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1056\/NEJMoa1704795","volume":"377","author":"S Peters","year":"2017","unstructured":"Peters S, Camidge DR, Shaw AT, et al. Alectinib versus Crizotinib in untreated ALK-Positive non-small-cell Lung Cancer. N Engl J Med. 2017;377(9):829\u201338.","journal-title":"N Engl J Med"},{"issue":"21","key":"13747_CR19","doi-asserted-by":"publisher","first-page":"2027","DOI":"10.1056\/NEJMoa1810171","volume":"379","author":"DR Camidge","year":"2018","unstructured":"Camidge DR, Kim HR, Ahn MJ, et al. Brigatinib versus Crizotinib in ALK-Positive non-small-cell Lung Cancer. N Engl J Med. 2018;379(21):2027\u201339.","journal-title":"N Engl J Med"},{"issue":"21","key":"13747_CR20","doi-asserted-by":"publisher","first-page":"2018","DOI":"10.1056\/NEJMoa2027187","volume":"383","author":"AT Shaw","year":"2020","unstructured":"Shaw AT, Bauer TM, de Marinis F, et al. First-line lorlatinib or Crizotinib in Advanced ALK-Positive Lung Cancer. N Engl J Med. 2020;383(21):2018\u201329.","journal-title":"N Engl J Med"},{"issue":"1","key":"13747_CR21","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1056\/NEJMoa1913662","volume":"382","author":"SS Ramalingam","year":"2020","unstructured":"Ramalingam SS, Vansteenkiste J, Planchard D, et al. Overall survival with Osimertinib in untreated, EGFR-Mutated Advanced NSCLC. N Engl J Med. 2020;382(1):41\u201350.","journal-title":"N Engl J Med"},{"issue":"20","key":"13747_CR22","doi-asserted-by":"publisher","first-page":"1919","DOI":"10.1056\/NEJMoa1709937","volume":"377","author":"SJ Antonia","year":"2017","unstructured":"Antonia SJ, Villegas A, Daniel D, et al. Durvalumab after Chemoradiotherapy in Stage III Non-small-cell Lung Cancer. N Engl J Med. 2017;377(20):1919\u201329.","journal-title":"N Engl J Med"},{"issue":"3","key":"13747_CR23","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1016\/S1470-2045(15)00553-7","volume":"17","author":"K Fujitani","year":"2016","unstructured":"Fujitani K, Yang HK, Mizusawa J, et al. Gastrectomy plus chemotherapy versus chemotherapy alone for advanced gastric cancer with a single non-curable factor (REGATTA): a phase 3, randomised controlled trial. Lancet Oncol. 2016;17(3):309\u201318.","journal-title":"Lancet Oncol"},{"issue":"9286","key":"13747_CR24","doi-asserted-by":"publisher","first-page":"966","DOI":"10.1016\/S0140-6736(01)06103-7","volume":"358","author":"GH Mickisch","year":"2001","unstructured":"Mickisch GH, Garin A, van Poppel H, et al. Radical nephrectomy plus interferon-alfa-based immunotherapy compared with interferon alfa alone in metastatic renal-cell carcinoma: a randomised trial. Lancet. 2001;358(9286):966\u201370.","journal-title":"Lancet"},{"issue":"7","key":"13747_CR25","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1055\/s-0034-1396666","volume":"63","author":"T Liu","year":"2015","unstructured":"Liu T, Liu H, Wang G, Zhang C, Liu B. Survival of M1a Non-small Cell Lung Cancer treated surgically: a retrospective single-centre study. Thorac Cardiovasc Surg. 2015;63(7):577\u201382.","journal-title":"Thorac Cardiovasc Surg"},{"issue":"8","key":"13747_CR26","doi-asserted-by":"publisher","first-page":"937","DOI":"10.1093\/jnci\/djad098","volume":"115","author":"NM Carroll","year":"2023","unstructured":"Carroll NM, Burnett-Hartman AN, Rendle KA, et al. Smoking status and the association between patient-level factors and survival among lung cancer patients. J Natl Cancer Inst. 2023;115(8):937\u201348.","journal-title":"J Natl Cancer Inst"},{"issue":"9","key":"13747_CR27","doi-asserted-by":"publisher","first-page":"1232","DOI":"10.7326\/M21-0252","volume":"174","author":"M Sheikh","year":"2021","unstructured":"Sheikh M, Mukeriya A, Shangina O, Brennan P, Zaridze D. Postdiagnosis Smoking Cessation and reduced risk for Lung Cancer Progression and Mortality: a prospective cohort study. Ann Intern Med. 2021;174(9):1232\u20139.","journal-title":"Ann Intern Med"}],"updated-by":[{"DOI":"10.1186\/s12885-025-14919-x","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2025,8,29]],"date-time":"2025-08-29T00:00:00Z","timestamp":1756425600000}}],"container-title":["BMC Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-025-13747-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12885-025-13747-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-025-13747-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,6]],"date-time":"2025-09-06T06:13:06Z","timestamp":1757139186000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmccancer.biomedcentral.com\/articles\/10.1186\/s12885-025-13747-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,21]]},"references-count":27,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["13747"],"URL":"https:\/\/doi.org\/10.1186\/s12885-025-13747-3","relation":{"correction":[{"id-type":"doi","id":"10.1186\/s12885-025-14919-x","asserted-by":"object"}]},"ISSN":["1471-2407"],"issn-type":[{"value":"1471-2407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2,21]]},"assertion":[{"value":"23 June 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 February 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 February 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 August 2025","order":4,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Update","order":5,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The original article has been updated: Table 2 is corrected.","order":6,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 August 2025","order":7,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":8,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A Correction to this paper has been published:","order":9,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"https:\/\/doi.org\/10.1186\/s12885-025-14919-x","URL":"https:\/\/doi.org\/10.1186\/s12885-025-14919-x","order":10,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was carried out in accordance with the Declaration of Helsinki and was approved by the ethics committee of Ethics Committee of Daping Hospital Hospital (approval number: 2024-01; approval date: January 17, 2024) and The First Affiliated Hospital of Chongqing Medical University (approval number: K2024-045-01; approval date: January 26, 2024). All patients signed the informed consent form prior to the surgery. The need for individual consent to the utilization of their clinicopathological data for scientific research purposes was waived by the committee.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not Applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"None.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Financial support and sponsorship"}},{"value":"The authors declare no competing interests.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"316"}}